C. Zandueta

A. Patiño-García, F. Lecanda, L. Sierrasesúmaga, 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Tumor–stromal interactions of the bone microenvironment: in vitro findings and potential in vivo relevance in metastatic lung cancer models

S. Vicent, F. Lecanda, D. Luis-Ravelo, 2011, Clinical & Experimental Metastasis.

Inhibition of Collagen Receptor Discoidin Domain Receptor-1 (DDR1) Reduces Cell Survival, Homing, and Colonization in Lung Cancer Bone Metastasis

F. Lecanda, M. Pajares, D. Luis-Ravelo, 2012, Clinical Cancer Research.

Human Cancer Biology InhibitionofCollagenReceptorDiscoidinDomainReceptor-1 ( DDR 1 ) Reduces Cell Survival , Homing , and Colonization in Lung Cancer Bone Metastasis

F. Lecanda, M. Pajares, D. Luis-Ravelo, 2012 .

Regulation of osteosarcoma cell lung metastasis by the c-Fos/AP-1 target FGFR1

A. Patiño-García, F. Lecanda, T. Kashima, 2016, Oncogene.

miRNA cargo within exosome‐like vesicle transfer influences metastatic bone colonization

E. Bandrés, F. Lecanda, D. Luis-Ravelo, 2014, Molecular oncology.

PDGFR signaling blockade in marrow stroma impairs lung cancer bone metastasis.

F. Lecanda, D. Luis-Ravelo, A. Calvo, 2011, Cancer research.

Therapeutics , Targets , and Chemical Biology PDGFR Signaling Blockade in Marrow Stroma Impairs Lung Cancer Bone Metastasis

F. Lecanda, D. Luis-Ravelo, A. Calvo, 2010 .

Combinatorial Nanomedicine Made of Squalenoyl-Gemcitabine and Edelfosine for the Treatment of Osteosarcoma

P. Couvreur, F. Lecanda, D. Desmaële, 2020, Cancers.

RHOB influences lung adenocarcinoma metastasis and resistance in a host‐sensitive manner

I. Wistuba, S. Vicent, F. Lecanda, 2014, Molecular oncology.

Regulation of osteosarcoma cell lung metastasis by the c-Fos/AP-1 target FGFR1

A. Patiño-García, F. Lecanda, T. Kashima, 2015, Oncogene.

Tumor ENPP1 (CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast Cancer

C. Ortiz de Solórzano, S. Vicent, I. Melero, 2022, Cancer discovery.

miR-326 associates with biochemical markers of bone turnover in lung cancer bone metastasis.

E. Bandrés, F. Lecanda, C. de la Piedra, 2013, Bone.

Receptor of activated protein C promotes metastasis and correlates with clinical outcome in lung adenocarcinoma.

I. Wistuba, F. Lecanda, M. Pajares, 2012, American journal of respiratory and critical care medicine.

EPCR promotes breast cancer progression by altering SPOCK1/testican 1-mediated 3D growth

R. Gomis, S. Vicent, F. Lecanda, 2017, Journal of Hematology & Oncology.

Sphere-derived tumor cells exhibit impaired metastasis by a host-mediated quiescent phenotype

F. Lecanda, M. Redrado, A. Calvo, 2015, Oncotarget.

Two cell line models to study multiorganic metastasis and immunotherapy in lung squamous cell carcinoma

Roman K. Thomas, I. Melero, M. Larrayoz, 2021, Disease Models & Mechanisms.

Tumor ENPP1(CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast Cancer.

C. Ortiz de Solórzano, S. Vicent, I. Melero, 2022, Cancer discovery.

P3.07-007 Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis

S. Vicent, F. Lecanda, M. Pajares, 2017 .

Profiling of Chemonaive Osteosarcoma and Paired-Normal Cells Identifies EBF2 as a Mediator of Osteoprotegerin Inhibition to Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Induced Apoptosis

A. Patiño-García, F. Lecanda, M. San Julián, 2009, Clinical Cancer Research.

The Oncolytic Adenovirus Δ24‐RGD in Combination With Cisplatin Exerts a Potent Anti‐Osteosarcoma Activity

A. Patiño-García, F. Lecanda, J. Fueyo, 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.